Renal cell carcinoma risk factors: Difference between revisions
Shanshan Cen (talk | contribs) No edit summary |
No edit summary |
||
| Line 25: | Line 25: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Kidney diseases]] | [[Category:Kidney diseases]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
Revision as of 19:59, 27 August 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Renal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Renal cell carcinoma risk factors On the Web |
|
American Roentgen Ray Society Images of Renal cell carcinoma risk factors |
|
Risk calculators and risk factors for Renal cell carcinoma risk factors |
Overview
The risk factors of renal cell carcinoma include cigarette smoking, obesity, hypertension, end-stage renal failure, acquired cystic renal disease, acetaminophen and analgesic drug use, asbestos or trichloroethylene exposure, tuberous sclerosis, von-Hippel Lindau, hereditary paraganglioma, leiomyomatosis, and birt-hogg-dube syndrome.
Risk factors
Most patients with renal cell carcinoma do not have typical risk factors. Established risk factors for the development of renal cell carcinoma are shown below:
- Active and passive cigarette smoking[1][2]
- Obesity[3][4]
- Hypertension
- End-stage renal failure[5][6]
- Acetaminophen and analgesic drug use[7]
- Asbestos or trichloroethylene exposure[7]
- Tuberous sclerosis[5][6]
- Von-Hippel Lindau[8]
- Hereditary paraganglioma[9]
- Leiomyomatosis
- Birt-Hogg-Dube syndrome[9]
References
- ↑ Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P (2005). "Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies". Int J Cancer. 114 (1): 101–8. doi:10.1002/ijc.20618. PMID 15523697.
- ↑ Yuan JM, Castelao JE, Gago-Dominguez M, Yu MC, Ross RK (1998). "Tobacco use in relation to renal cell carcinoma". Cancer Epidemiol Biomarkers Prev. 7 (5): 429–33. PMID 9610793.
- ↑ Bjørge T, Tretli S, Engeland A (2004). "Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women". Am J Epidemiol. 160 (12): 1168–76. doi:10.1093/aje/. PMID 15583369.
- ↑ van Dijk BA, Schouten LJ, Kiemeney LA, Goldbohm RA, van den Brandt PA (2004). "Relation of height, body mass, energy intake, and physical activity to risk of renal cell carcinoma: results from the Netherlands Cohort Study". Am J Epidemiol. 160 (12): 1159–67. doi:10.1093/aje/. PMID 15583368.
- ↑ 5.0 5.1 5.2 Ishikawa I, Saito Y, Asaka M, Tomosugi N, Yuri T, Watanabe M; et al. (2003). "Twenty-year follow-up of acquired renal cystic disease". Clin Nephrol. 59 (3): 153–9. PMID 12653256.
- ↑ 6.0 6.1 6.2 Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA (2006). "Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors". Kidney Int. 70 (10): 1777–82. doi:10.1038/sj.ki.5001853. PMID 17003820.
- ↑ 7.0 7.1 McCredie M, Pommer W, McLaughlin JK, Stewart JH, Lindblad P, Mandel JS; et al. (1995). "International renal-cell cancer study. II. Analgesics". Int J Cancer. 60 (3): 345–9. PMID 7829242.
- ↑ Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM; et al. (2003). "von Hippel-Lindau disease". Lancet. 361 (9374): 2059–67. doi:10.1016/S0140-6736(03)13643-4. PMID 12814730.
- ↑ 9.0 9.1 Rini BI, Campbell SC, Escudier B (2009). "Renal cell carcinoma". Lancet. 373 (9669): 1119–32. doi:10.1016/S0140-6736(09)60229-4. PMID 19269025.